ASHPOfficial

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast we briefly highlight some aspects of pharmacy services in tribal and indigenous settings. The speakers here describe their experiences and answer some questions about this unique area of service. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.